ZyVersa Therapeutics Inc. (ZVSA) — Strategic Asset Allocation Index
ZyVersa Therapeutics Inc. (ZVSA) has a Strategic Asset Allocation Index of 0.1% as of December 2022. Strategic assets (PP&E of $115.70K plus long-term investments of $-) total $115.70K, measured against net assets of $99.99 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ZyVersa Therapeutics Inc. balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ZyVersa Therapeutics Inc. Strategic Asset Allocation Index (2022–2022)
This chart shows how ZyVersa Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the index stands at 0.1%, representing strategic assets of $115.70K against net assets of $99.99 Million USD. For live market cap and overall valuation, see ZVSA company net worth.
Annual Strategic Asset Allocation Index for ZyVersa Therapeutics Inc. (2022–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ZyVersa Therapeutics Inc. from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ZVSA book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $115.70K | $115.70K | $- | $99.99 Million | — |